Overview
Pilocytic astrocytoma (PA), also known as juvenile pilocytic astrocytoma or cystic cerebellar astrocytoma, is a slow-growing (WHO grade I) brain tumor that arises from astrocytes, a type of glial cell in the central nervous system. It is the most common brain tumor in children, typically occurring in the cerebellum (posterior fossa), but can also develop in the optic pathways, hypothalamus, brainstem, and cerebral hemispheres. The tumor is generally well-circumscribed and often contains both solid and cystic components. Pilocytic astrocytomas are characterized histologically by biphasic architecture with compact bipolar (piloid) cells and loose-textured multipolar cells, along with Rosenthal fibers and eosinophilic granular bodies. Symptoms depend on the tumor's location and size. Cerebellar tumors commonly present with headaches, nausea, vomiting, balance difficulties (ataxia), and signs of increased intracranial pressure due to obstructive hydrocephalus. Optic pathway tumors may cause visual disturbances, proptosis, or hormonal abnormalities when the hypothalamus is involved. Pilocytic astrocytomas are frequently associated with neurofibromatosis type 1 (NF1), particularly optic pathway gliomas. The BRAF-KIAA1549 fusion gene is the most common molecular alteration found in sporadic cases, resulting in activation of the MAPK/ERK signaling pathway. The primary treatment is surgical resection, which is often curative when gross total removal is achieved, with excellent long-term survival rates exceeding 90% at 10 years. When complete resection is not feasible due to tumor location (e.g., hypothalamic or brainstem tumors), chemotherapy and/or radiation therapy may be employed. Targeted therapies, including MEK inhibitors and BRAF inhibitors, have shown promise in recurrent or progressive cases, particularly those harboring BRAF alterations. Overall, pilocytic astrocytoma carries one of the most favorable prognoses among all central nervous system tumors.
Sporadic
Usually appears on its own, not inherited from a parent
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
1 availableOjemda
Treatment of pediatric patients 6 months of age and older and young adults with relapsed or refractory pediatric low-grade glioma (pLGG) harboring a BRAF fusion or rearrangement.
Clinical Trials
View all trials with filters →No actively recruiting trials found for Pilocytic astrocytoma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pilocytic astrocytoma.
Community
No community posts yet. Be the first to share your experience with Pilocytic astrocytoma.
Start the conversation →Latest news about Pilocytic astrocytoma
No recent news articles for Pilocytic astrocytoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pilocytic astrocytoma
What is Pilocytic astrocytoma?
Pilocytic astrocytoma (PA), also known as juvenile pilocytic astrocytoma or cystic cerebellar astrocytoma, is a slow-growing (WHO grade I) brain tumor that arises from astrocytes, a type of glial cell in the central nervous system. It is the most common brain tumor in children, typically occurring in the cerebellum (posterior fossa), but can also develop in the optic pathways, hypothalamus, brainstem, and cerebral hemispheres. The tumor is generally well-circumscribed and often contains both solid and cystic components. Pilocytic astrocytomas are characterized histologically by biphasic archit
How is Pilocytic astrocytoma inherited?
Pilocytic astrocytoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pilocytic astrocytoma typically begin?
Typical onset of Pilocytic astrocytoma is childhood. Age of onset can vary across affected individuals.
Which specialists treat Pilocytic astrocytoma?
19 specialists and care centers treating Pilocytic astrocytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.